Marshall Wace
HGEN

Marshall Wace’s HUMANIGEN, INC. HGEN Stock Holding History

Marshall Wace’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-608,736
Closed -$1.08M – 3949
2022
Q2 		$1.08M Sell
608,736
-624,232
-51% -$1.4M ﹤0.01% 2397
2022
Q1 		$3.71M Buy
1,232,968
+159,566
+15% +$427K 0.01% 1621
2021
Q4 		$3.99M Buy
+1,073,402
New +$6.28M 0.01% 1540
2021
Q3 		– Sell
-407,563
Closed -$7.08M – 3556
2021
Q2 		$7.08M Sell
407,563
-72,705
-15% -$1.33M 0.03% 647
2021
Q1 		$9.17M Buy
+480,268
New +$8.77M 0.04% 500

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace's HGEN Position: Q3 2022 in Review

Marshall Wace sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 608,736 shares — an estimated $1.08M sold.

Marshall Wace first reported a position in HGEN in Q1 2021 and held it in 5 quarters. The position peaked at $9.17M in Q1 2021. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Marshall Wace reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 608,736 HUMANIGEN, INC. shares in Q3 2022, an estimated $1.08M.
  • Marshall Wace first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 5 quarters.
  • Marshall Wace's HUMANIGEN, INC. position peaked at $9.17M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.